DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ISOMETHEPTENE MUCATE
4
Small molecule
Approved
Unknown
Unknown
Migraine Disorders
Unknown
ISOMETHEPTENE MUCATE
×
Maximum Phase:
4
First Approval:
None
UNII:
8O120FDS6P
Molecule Type:
Small molecule
Molecular Formula:
C24H48N2O8
Molecular Weight:
492.65
AlogP:
2.34
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEVOMEPROMAZINE MALEATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LEVOMEPROMAZINE MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
5KN5Y9V01K
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O5S
Molecular Weight:
444.55
AlogP:
4.5
PSA:
15.71
HBD:
0.0
HBA:
#RotB:
5.0
Source:
POTASSIUM PERMANGANATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
POTASSIUM PERMANGANATE
×
Maximum Phase:
4
First Approval:
None
UNII:
00OT1QX5U4
Molecule Type:
Small molecule
Molecular Formula:
KMnO4
Molecular Weight:
158.03
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
4
Combination
Approved
OTHER
INJECTION; ORAL; RECTAL
Unknown
Unknown
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE MALEATE; BENAZEPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IFENPRODIL
4
Small molecule
Approved
Unknown
Unknown
Stress Disorders, Post-Traumatic; Idiopathic Pulmonary Fibrosis; Severe Acute Respiratory Syndrome; Cardiovascular Diseases
Unknown
IFENPRODIL
×
Maximum Phase:
4
First Approval:
None
UNII:
R8OE3P6O5S
Molecule Type:
Small molecule
Molecular Formula:
C21H27NO2
Molecular Weight:
325.45
AlogP:
3.77
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
5.0
Source:
1
2
…
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA